Future Retirement Success
  • Politics
  • Business
  • Investing
  • Stocks
  • Politics
  • Business
  • Investing
  • Stocks

Future Retirement Success

Investing

Marijuana Should Be De-Scheduled, Not Re-Scheduled

by August 30, 2023
August 30, 2023
Marijuana Should Be De-Scheduled, Not Re-Scheduled

Jeffrey A. Singer

Bloomberg News is reporting that U.S. Department of Health and Human Services Assistant Secretary for Health Rachel Levine has sent a letter to Drug Enforcement Administrator Anne Milgram asking her agency to reclassify marijuana (cannabis) as a Schedule III drug. The DEA defines Schedule III drugs as “drugs with a moderate to low potential for physical and psychological dependence.” The agency currently classifies marijuana as Schedule I: a drug “with no currently accepted medical use and a high potential for abuse.” Of course, that definition begs the question, “Currently accepted by whom?” But an even more important question is, “Why should a plant people have been growing and using recreationally for millennia be scheduled as a drug when alcohol is not?”

When Congress authorized the law enforcement agency to judge the clinical applications, efficacy, and potential dangers of drugs, it authorized cops to practice medicine. And they have been engaging in malpractice. For example, no serious person would argue that marijuana has “no currently accepted medical use.” As far back as 1916, Sir William Osler, the so‐​called “father of modern medicine,” recommended cannabis as the “drug of choice” for treating migraines. But cannabis’s history of “accepted medical use” dates back to at least 2800 B.C.

The DEA also schedules diamorphine (brand‐​named “heroin” by Bayer, its manufacturer in the 19th century) Schedule I even though it is legally used in the U.K. and much of the developed world to treat pain and is employed for medication‐​assisted treatment of opioid use disorder (OUD) in Switzerland, the Netherlands, Germany, Canada, the U.K, Denmark, and Spain.

And even though a bipartisan consensus is emerging that psychedelics may be extremely helpful in treating post‐​traumatic stress disorder, depression, addiction, and compulsive disorders, and in end‐​of‐​life care, the DEA placed them on Schedule I, depriving researchers, clinicians, and patients of these tools for 50 years.

In her letter to the DEA, Assistant Secretary Levine wrote that her request was based upon the Food and Drug Administration’s review of marijuana’s classification. If the law enforcement agency reschedules marijuana as Schedule III, it will undoubtedly make it easier for clinical researchers to conduct high‐​quality studies on the plant’s clinical uses and effectiveness. But it still means that the millions of people who use marijuana recreationally rather than medicinally are committing a federal crime. It also ensures that a black market in the prohibited plant will continue to thrive.

Instead of deferring to administrative agencies to reschedule marijuana, Congress can and should de‐​schedule it.

0
FacebookTwitterGoogle +Pinterest
previous post
The Ord Oracle August 29, 2023
next post
Do the Presidential Candidates Like the Constitution, or Just the Idea of it?

You may also like

Should the Fed Devalue Our Currency to Implement...

July 29, 2022

Friday Feature: Gather Forest School

April 21, 2023

A Tentative Step Toward Local Government Accountability in...

January 31, 2024

A Setback for Election Reformers?

November 20, 2024

The Pros and Cons of Decriminalization

September 29, 2023

The State of President Joe Biden’s Inflation Analysis

March 5, 2024

Gender Board Quotas: Still Unhelpful to Working Women

September 7, 2023

Friday Feature: Institute for Catholic Liberal Education

July 21, 2023

Demystifying AI Experimentation and the Startup Ecosystem

May 1, 2024

Social Security Pays Excessive Benefits to the Highest-Income...

February 15, 2024

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • Silver’s Surge is No Fluke—Here’s the Strange Ratio Driving It

      June 6, 2025
    • Friday Feature: Incubate Debate

      June 6, 2025
    • Risch urges ‘top to bottom’ USAID spending review after waste, fraud exposed

      June 6, 2025
    • Universities in Libertarian Land

      June 6, 2025
    • Elon Musk may speak to Trump aides in push to calm feud

      June 6, 2025
    • Everyone Talks About Leaving a Better Planet for Our Children: Why Don’t We Leave Better Children for Our Planet?

      June 6, 2025

    Categories

    • Business (8,149)
    • Investing (2,013)
    • Politics (15,545)
    • Stocks (3,131)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: futureretirementsuccess.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 futureretirementsuccess.com | All Rights Reserved